13 June 2012 - Jazz Pharmaceuticals plc (Nasdaq: JAZZ), a specialty biopharmaceutical company, has announced today that it has completed the acquisition of EUSA Pharma, a privately-held, specialty pharmaceutical company with a commercial presence in the United States and the EU, and a global distrib...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up